dc.contributor | History of Twentieth Century Medicine Group | |
dc.contributor | History of Modern Biomedicine Research Group | |
dc.date.accessioned | 2017-05-22T13:26:15Z | |
dc.date.available | 2017-05-22T13:26:15Z | |
dc.date.issued | 22/05/2017 | |
dc.date.submitted | 2017-05-22T13:57:37.567Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23253 | |
dc.description.abstract | Selection of photos taken at the Witness Seminar “Leukaemia” held by the History of Twentieth Century Medicine Group, 15-May-2001. Participants: Sir Christopher Booth, Professor Daniel Catovsky, Professor Derek Crowther, Professor David Galton, Professor John Goldman (Chair), Dr David Grant, Professor Frank Hayhoe, Professor Victor Hoffbrand, Dr Peter Hunter, Professor Humphrey Kay, Professor Sir John Lilleyman, Professor Ian MacLennan, Dr Gordon Piller, Professor Ray Powles, Dr Rosemary Shannon, Dr John Stock, Dr Tilli Tansey, Professor John Walker-Smith, and Dr Eve Wiltshaw. | en_US |
dc.description.sponsorship | The History of Modern Biomedicine Research Group is funded by the Wellcome Trust, which is a registered charity (no. 210183). The creation and curation of the current photo collection has been funded by the Wellcome Trust Strategic Award entitled “Makers of modern biomedicine: testimonies and legacy” (2012-2017; awarded to Professor Tilli Tansey). | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | History of Modern Biomedicine Witness Seminars (Photo Collection);eWS15.01 | |
dc.relation.ispartofseries | History of Modern Biomedicine Witness Seminars (Photo Collection);eWS15.02 | |
dc.relation.ispartofseries | History of Modern Biomedicine Witness Seminars (Photo Collection);eWS15.03 | |
dc.relation.isbasedon | https://qmro.qmul.ac.uk/jspui/handle/123456789/2766 | |
dc.rights | Attribution 3.0 United States | |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | |
dc.subject | acute lymphoblastic leukaemia (ALL) | en_US |
dc.subject | acute myeloid leukaemia (AML) | en_US |
dc.subject | chemotherapy | en_US |
dc.subject | immunotherapy | en_US |
dc.subject | MRC trials | en_US |
dc.subject | acute promyelocytic leukaemia (APML) | en_US |
dc.subject | alkylating agents | en_US |
dc.subject | aminopterin | en_US |
dc.subject | BCG vaccine | en_US |
dc.subject | blast cells | en_US |
dc.subject | bone marrow transplantation | en_US |
dc.subject | busulphan | en_US |
dc.subject | toxic effects of chemotherapy | en_US |
dc.subject | blood transfusions | en_US |
dc.subject | childhood leukaemia | en_US |
dc.subject | chromosome abnormalities | en_US |
dc.subject | chronic myeloid leukaemia | en_US |
dc.subject | cytogenetics | en_US |
dc.subject | folic acid | en_US |
dc.subject | immunological techniques | en_US |
dc.subject | Imuran (azathioprine) | en_US |
dc.subject | lymphoma | en_US |
dc.subject | Concord trial | en_US |
dc.subject | methotrexate | en_US |
dc.subject | molecular biology | en_US |
dc.subject | National Health Service (NHS) | en_US |
dc.subject | pancytopenia | en_US |
dc.subject | platelet transfusion | en_US |
dc.subject | radiotherapy | en_US |
dc.subject | stem cells | en_US |
dc.subject | T lymphoblastic leukaemia (Sternberg lymphoma) | en_US |
dc.subject | erminal deoxynucleotidyl transferase (TdT) | en_US |
dc.title | WS15: Leukaemia (15-May-2001) | en_US |
dc.type | Image | en_US |